BIRC3, VCAN, CTAG1B, SOD1, and KYNU promoted the survival and proliferation of cancer cells, inhibited cancer cell apoptosis, and were related to poor prognosis and treatment resistance (Jin et al., 2018; Liu et al., 2020b; Al‐Mansoob et al., 2021; Frazzi, 2021; Li et al., 2021). Here, BIRC3 is linked to cancer.